학술논문

NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Document Type
Article
Source
Breast Cancer Research; 4/22/2024, Vol. 26 Issue 1, p1-13, 13p
Subject
HER2 positive breast cancer
METASTATIC breast cancer
CLINICAL trial registries
CIRCULATING tumor DNA
PROGRESSION-free survival
Language
ISSN
14655411
Abstract
Copyright of Breast Cancer Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)